Although a curable disease, tuberculosis (TB) remains a significant cause of mortality worldwide. To create a basis for further research into TB and HIV-associated mortality in Cape Town, we conducted a retrospective analysis of deaths occurring during TB treatment. A binomial log-linear regression model was used to investigate risk factors associated with death during TB treatment. We specifically looked at interactions between HIV infection and various other risk factors towards the risk of death from TB during treatment.
The history of sub-Saharan Africa has been defined and determined to a large extent by the struggle against tropical diseases, many of them vector borne, including malaria, leishmaniasis, trypanosomiasis and many others. To add to this burden our continent has now to deal with the ravages of HIV and the consequent rise in tuberculosis. In this issue of the SACEMA Quarterly we discuss some of the key problems and ways in which we might be able to address and mitigate some of the challenges that we face in this regard.
It is known that in high TB incidence settings the rate of recurrent TB disease is much higher than the rate for first-time disease. It is not clear why the rate of reinfection disease can be elevated compared to the rate of primary disease. We set about attempting to estimate the actual values of the risk of reinfection and the rate of progress to disease for the high-incidence community of Ravensmead-Uitsig in Cape Town.
In the SACEMA Quarterly of November 2015 we published an item from Alide Dasnois about compensating miners for the burden of lung disease. On 6 March 2016 City Press published an article titled “Silicosis claims: Anglo has to cough up nearly R500m” which reports on a first step in the process of paying the individual claims.
Alide Dasnois, a South African journalist and former editor of the Cape Times, has written an an article titled “The long battle to get the mines to cough up” which is about compensating miners for the burden of lung disease. The importance of this issue has been highlighted before in a SACEMA Quarterly article by Tony Davies giving an historical overview on occupational lung disease in South Africa.
A considerable share of South Africa’s tuberculosis burden affects those people who have previously been treated for tuberculosis – many of them successfully. In a retrospective cohort study that was conducted using tuberculosis treatment register data from two communities in suburban Cape Town, it was found that the hazard rate of re-treatment for smear-positive tuberculosis was between 3- and 5.26-times higher in tuberculosis cases who had defaulted from treatment compared to successfully treated cases. But although the rate of re-treatment was substantially higher among defaulters, cases after treatment success account for the vast majority of smear-positive re-treatment cases due to the fact that far more tuberculosis cases were successfully treated than had defaulted.
The Mycobacterium tuberculosis (TB) bacilli’s potency to cause persistent latent infection that is unresponsive to the current cocktail of TB drugs is strongly associated with its ability to adapt to changing intracellular environments, and tolerating, evading and subverting host defence mechanisms. We applied a combination of bioinformatics and mathematical modelling methods to enhance the understanding Read More
The introduction and scale-up of new tools for the diagnosis of tuberculosis (TB) has the potential to make a huge difference to the lives of millions of people. To realise these benefits and make the best decisions, policy makers need answers to many difficult questions about which new tools to implement and where in the diagnostic algorithm to apply them cost effectively. Here we explore virtual implementation as a tool to predict the health system, patient, and community impacts of alternative diagnostics and diagnostic algorithms for TB, in order to facilitate context specific decisions on scale-up. Virtual implementation is an approach that can model the impacts of implementation of a new diagnostics by taking data from the context being considered alongside data from contexts where the new technology has been implemented (probably as a trial).
A new case of TB is the outcome of a recent infection event (primary TB) or is the result of the reactivation of a latent infection acquired some years previously. In a community where TB is endemic it is important to know the extent to which primary cases contribute to the overall burden as this can inform strategies to deal with the epidemic. This article discusses the methods for estimating the proportion of cases due to recent transmission by using cluster analysis. Sputum specimens from cases reporting to clinics are cultured and the TB strains are identified, commonly using molecular techniques of DNA ‘fingerprinting’. By comparing these fingerprints from various patients it becomes possible to classify them as unique or clustered. The proportion of clustered individuals can then be used as an indicator of the proportion of on-going or recent transmission.
Although antibiotics have saved millions of lives, their use and misuse has often led to the development of resistance in the agents that they are intended to fight. SACEMA's Brian Williams recently published a commentary on an article in published in Science Translational Medicine in which Sergeev et al. used dynamical models to investigate the Read More